# SR One Capital Management, LP 13F Q2 2026: $1 billion

SR One Capital Management, LP reported $1 billion in 13F securities across 15 positions for the quarter ended June 30, 2026, in a holdings report filed August 12, 2026. Its largest holding was Veradermics Inc at $295 million, 28.4% of the reported value. Since Q1 2026 it opened 3 new positions and exited 2.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $1,039,007,705
- Positions: 15
- Filed: August 12, 2026
- Report type: 13F holdings report
- CIK: 1910264
- Form 13F file number: 028-21964
- CRD number: 306361
- Business address: 929 Main Street Suite 200, Redwood City, CA 94063
- SEC filing: [0001193125-26-347065](https://www.sec.gov/Archives/edgar/data/1910264/000119312526347065/0001193125-26-347065-index.htm)
- Investment adviser record: [Form ADV on SpecStream](https://specstream.ai/data/investment-advisers/firm/sr-one-capital-management-lp-306361)

## Top 15 holdings by value

The largest of 15 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Veradermics Inc](https://specstream.ai/data/institutional-holders/veradermics-inc-922967104) | COMMON STOCK | 2,401,868 | $295.3 million | No change |
| [Zenas Biopharma Inc](https://specstream.ai/data/institutional-holders/zenas-biopharma-inc-98937l105) | COM | 5,037,854 | $127.9 million | No change |
| [Crispr Therapeutics AG](https://specstream.ai/data/institutional-holders/crispr-therapeutics-ag-h17182108) | NAMEN AKT | 2,038,763 | $111.2 million | No change |
| [Avalyn Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/avalyn-pharmaceuticals-inc-05348y105) | COM SHS | 3,308,649 | $108.9 million | New |
| [Design Therapeutics Inc](https://specstream.ai/data/institutional-holders/design-therapeutics-inc-25056l103) | COM | 6,526,476 | $94.4 million | No change |
| [Odyssey Therapeutics Inc](https://specstream.ai/data/institutional-holders/odyssey-therapeutics-inc-67613t104) | COMMON STOCK | 3,794,883 | $71 million | New |
| [Alumis Inc](https://specstream.ai/data/institutional-holders/alumis-inc-022307102) | COM | 1,959,896 | $55.2 million | No change |
| [Oric Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/oric-pharmaceuticals-inc-68622p109) | COM | 4,615,384 | $50 million | +100,455 |
| [Mineralys Therapeutics Inc](https://specstream.ai/data/institutional-holders/mineralys-therapeutics-inc-603170101) | COM | 1,563,966 | $42.2 million | No change |
| [Ars Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/ars-pharmaceuticals-inc-82835w108) | COM | 4,012,903 | $32.1 million | No change |
| [Mobia Med Inc](https://specstream.ai/data/institutional-holders/mobia-med-inc-60705v103) | COMMON STOCK | 1,986,072 | $26.6 million | New |
| [Nkarta Inc](https://specstream.ai/data/institutional-holders/nkarta-inc-65487u108) | COM | 3,333,333 | $9.4 million | No change |
| [Oculis Holding AG](https://specstream.ai/data/institutional-holders/oculis-holding-ag-h5870p102) | ORDINARY SHARES | 641,022 | $8.9 million | No change |
| [Ultragenyx Pharmaceutical in](https://specstream.ai/data/institutional-holders/ultragenyx-pharmaceutical-in-90400d108) | COM | 137,753 | $4.6 million | No change |
| Engene Holdings Inc | COM | 747,750 | $1.3 million | No change |

## New positions in Q2 2026

3 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Avalyn Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/avalyn-pharmaceuticals-inc-05348y105) | COM SHS | 3,308,649 | $108.9 million |
| [Odyssey Therapeutics Inc](https://specstream.ai/data/institutional-holders/odyssey-therapeutics-inc-67613t104) | COMMON STOCK | 3,794,883 | $71 million |
| [Mobia Med Inc](https://specstream.ai/data/institutional-holders/mobia-med-inc-60705v103) | COMMON STOCK | 1,986,072 | $26.6 million |

## Positions exited in Q2 2026

2 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| Arcellx Inc | COMMON STOCK | 2,346,630 | $269.4 million |
| [Oruka Therapeutics Inc](https://specstream.ai/data/institutional-holders/oruka-therapeutics-inc-687604108) | COM | 430,330 | $21.1 million |

## Also on SpecStream

- [SR One Capital Management, LP Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1910264/000119312526347065/0001193125-26-347065-index.htm)
- [SR One Capital Management, LP investment adviser record (Form ADV)](https://specstream.ai/data/investment-advisers/firm/sr-one-capital-management-lp-306361)
- [Largest 13F filers in California](https://specstream.ai/data/institutional-holdings/state/california)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Redwood City, California

- [Real estate firms in Redwood City, California](https://specstream.ai/data/businesses/real-estate-firms/redwood-city-california-united-states)
- [Law firms in Redwood City, California](https://specstream.ai/data/businesses/law-firms/redwood-city-california-united-states)
- [Financial services firms in Redwood City, California](https://specstream.ai/data/businesses/financial-services-firms/redwood-city-california-united-states)
- [Contractors in Redwood City, California](https://specstream.ai/data/businesses/contractors/redwood-city-california-united-states)
- [Biotechnology companies in Redwood City, California](https://specstream.ai/data/businesses/biotechnology-companies/redwood-city-california-united-states)
- [Mexican restaurants in Redwood City, California](https://specstream.ai/data/businesses/mexican-restaurants/redwood-city-california-united-states)
